These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9576284

  • 1. Pancreatic carcinoma: correlation between E-cadherin and alpha-catenin expression status and liver metastasis.
    Gunji N, Oda T, Todoroki T, Kanazawa N, Kawamoto T, Yuzawa K, Scarpa A, Fukao K.
    Cancer; 1998 May 01; 82(9):1649-56. PubMed ID: 9576284
    [Abstract] [Full Text] [Related]

  • 2. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.
    Karayiannakis AJ, Syrigos KN, Polychronidis A, Simopoulos C.
    Anticancer Res; 2001 May 01; 21(6A):4127-34. PubMed ID: 11911306
    [Abstract] [Full Text] [Related]

  • 3. Relationship between expressions of E-cadherin and alpha-catenin and biological behaviors of human pancreatic cancer.
    Li YJ, Meng YX, Ji XR.
    Hepatobiliary Pancreat Dis Int; 2003 Aug 01; 2(3):471-7. PubMed ID: 14599963
    [Abstract] [Full Text] [Related]

  • 4. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function.
    Ewing CM, Ru N, Morton RA, Robinson JC, Wheelock MJ, Johnson KR, Barrett JC, Isaacs WB.
    Cancer Res; 1995 Nov 01; 55(21):4813-7. PubMed ID: 7585512
    [Abstract] [Full Text] [Related]

  • 5. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
    Chetty R, Serra S, Asa SL.
    Am J Surg Pathol; 2008 Mar 01; 32(3):413-9. PubMed ID: 18300809
    [Abstract] [Full Text] [Related]

  • 6. Reduced alpha-catenin and E-cadherin expression in breast cancer.
    Rimm DL, Sinard JH, Morrow JS.
    Lab Invest; 1995 May 01; 72(5):506-12. PubMed ID: 7745946
    [Abstract] [Full Text] [Related]

  • 7. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
    Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL.
    J Pathol; 1998 Jul 01; 185(3):262-6. PubMed ID: 9771479
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. alpha-catenin is a significant prognostic factor than E-cadherin in esophageal squamous cell carcinoma.
    Setoyama T, Natsugoe S, Okumura H, Matsumoto M, Uchikado Y, Yokomakura N, Ishigami S, Aikou T.
    J Surg Oncol; 2007 Feb 01; 95(2):148-55. PubMed ID: 17262732
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors.
    Marques FR, Fonsechi-Carvasan GA, De Angelo Andrade LA, Böttcher-Luiz F.
    Gynecol Oncol; 2004 Jul 01; 94(1):16-24. PubMed ID: 15262114
    [Abstract] [Full Text] [Related]

  • 11. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G, Scarpa A, Puppa G, Veronesi G, Spaggiari L, Pasini F, Maisonneuve P, Iannucci A, Arrigoni G, Viale G.
    Cancer; 2005 Mar 15; 103(6):1154-64. PubMed ID: 15712207
    [Abstract] [Full Text] [Related]

  • 12. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M, Lee HK, Kang YK.
    Anticancer Res; 2003 Mar 15; 23(2B):1581-8. PubMed ID: 12820426
    [Abstract] [Full Text] [Related]

  • 13. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
    Yoshida R, Kimura N, Harada Y, Ohuchi N.
    Int J Oncol; 2001 Mar 15; 18(3):513-20. PubMed ID: 11179480
    [Abstract] [Full Text] [Related]

  • 14. Alterations of the cadherin-catenin cell adhesion system in cancers.
    Kanai Y, Oda T, Shimoyama Y, Ochiai A, Oyama T, Yoshiura K, Akimoto S, Yamada T, Hirohashi S.
    Princess Takamatsu Symp; 1994 Mar 15; 24():51-62. PubMed ID: 8983063
    [Abstract] [Full Text] [Related]

  • 15. Expression of E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma: an immunohistochemical study.
    Hidaka N, Nagao T, Asoh A, Kondo Y, Nagao K.
    Mod Pathol; 1998 Nov 15; 11(11):1039-45. PubMed ID: 9831199
    [Abstract] [Full Text] [Related]

  • 16. Coordinate recruitment of E-cadherin and ALCAM to cell-cell contacts by alpha-catenin.
    Tomita K, van Bokhoven A, Jansen CF, Bussemakers MJ, Schalken JA.
    Biochem Biophys Res Commun; 2000 Jan 27; 267(3):870-4. PubMed ID: 10673383
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness.
    Shimoyama Y, Nagafuchi A, Fujita S, Gotoh M, Takeichi M, Tsukita S, Hirohashi S.
    Cancer Res; 1992 Oct 15; 52(20):5770-4. PubMed ID: 1394201
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines.
    Menke A, Philippi C, Vogelmann R, Seidel B, Lutz MP, Adler G, Wedlich D.
    Cancer Res; 2001 Apr 15; 61(8):3508-17. PubMed ID: 11309315
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.